Envofolimab and Lenvatinib Combined With Gemcitabine Plus Cisplatin for Advanced BTC as First-Line Treatment(ENLIGHTEN)

NCT05410197 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

43

Enrollment

OTHER

Sponsor class

Conditions

Advanced Biliary Tract Cancer

Interventions

DRUG: Envofolimab
DRUG: Lenvatinib
DRUG: Gemcitabine
DRUG: Cisplatin

Sponsor

Sun Yat-sen University